Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against β-amyloid
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against β-amyloid
Authors
Keywords
-
Journal
Science Signaling
Volume 12, Issue 587, Pages eaaw9318
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-06-26
DOI
10.1126/scisignal.aaw9318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil
- (2018) Katherine J. Sellers et al. Alzheimers & Dementia
- Distinct and complementary functions of rho kinase isoforms ROCK1 and ROCK2 in prefrontal cortex structural plasticity
- (2018) Kelsey M. Greathouse et al. Brain Structure & Function
- Dendritic spine remodeling accompanies Alzheimer’s disease pathology and genetic susceptibility in cognitively normal aging
- (2018) Benjamin D. Boros et al. NEUROBIOLOGY OF AGING
- Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation
- (2018) Travis Rush et al. JOURNAL OF NEUROSCIENCE
- Regulation of RhoA activity by the cellular prion protein
- (2017) Hee-Jun Kim et al. Cell Death & Disease
- LIM kinases: cofilin and beyond
- (2017) Chloé Prunier et al. Oncotarget
- Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential after Disease Onset
- (2017) René Günther et al. Frontiers in Pharmacology
- Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
- (2016) Keith A. Vossel et al. ANNALS OF NEUROLOGY
- Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain
- (2016) Benjamin W. Henderson et al. JOURNAL OF NEUROCHEMISTRY
- Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
- (2016) E. G. Gentry et al. JOURNAL OF NEUROSCIENCE
- Asymmetric division of contractile domains couples cell positioning and fate specification
- (2016) Jean-Léon Maître et al. NATURE
- Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
- (2016) Lars Tatenhorst et al. Acta Neuropathologica Communications
- Real-time two- and three-dimensional imaging of monocyte motility and navigation on planar surfaces and in collagen matrices: roles of Rho
- (2016) Robert Bzymek et al. Scientific Reports
- Bis-aryl Urea Derivatives as Potent and Selective LIM Kinase (Limk) Inhibitors
- (2015) Yan Yin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
- (2015) Yangbo Feng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tau-Mediated NMDA Receptor Impairment Underlies Dysfunction of a Selectively Vulnerable Network in a Mouse Model of Frontotemporal Dementia
- (2014) Brian A. Warmus et al. JOURNAL OF NEUROSCIENCE
- Spine neck plasticity regulates compartmentalization of synapses
- (2014) Jan Tønnesen et al. NATURE NEUROSCIENCE
- Dendritic Structural Degeneration Is Functionally Linked to Cellular Hyperexcitability in a Mouse Model of Alzheimer’s Disease
- (2014) Zuzana Šišková et al. NEURON
- ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
- (2014) J C Koch et al. Cell Death & Disease
- Rho kinase inhibitors: a patent review (2012 – 2013)
- (2013) Yangbo Feng et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Pharmacologic Inhibition of ROCK2 Suppresses Amyloid- Production in an Alzheimer's Disease Mouse Model
- (2013) J. H. Herskowitz et al. JOURNAL OF NEUROSCIENCE
- Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice
- (2013) Julio Pozueta et al. Nature Communications
- Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
- (2013) Keith A. Vossel et al. JAMA Neurology
- GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production
- (2012) Jeremy H. Herskowitz et al. MOLECULAR BIOLOGY OF THE CELL
- Dendritic spine changes associated with normal aging
- (2012) D.L. Dickstein et al. NEUROSCIENCE
- Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
- (2012) P. E. Sanchez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Critical role of soluble amyloid- for early hippocampal hyperactivity in a mouse model of Alzheimer's disease
- (2012) M. A. Busche et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators
- (2011) Fabrizio Manetti MEDICINAL RESEARCH REVIEWS
- High-throughput, detailed, cell-specific neuroanatomy of dendritic spines using microinjection and confocal microscopy
- (2011) Dani Dumitriu et al. Nature Protocols
- Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11/SORLA Alters Amyloid-β Production
- (2010) Jeremy H. Herskowitz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lifeact mice for studying F-actin dynamics
- (2010) Julia Riedl et al. NATURE METHODS
- Amyloid -Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
- (2009) R. Minkeviciene et al. JOURNAL OF NEUROSCIENCE
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- Lifeact: a versatile marker to visualize F-actin
- (2008) Julia Riedl et al. NATURE METHODS
- Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease
- (2008) M. A. Busche et al. SCIENCE
- Protein Synthesis and Neurotrophin-Dependent Structural Plasticity of Single Dendritic Spines
- (2008) J.-i. Tanaka et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started